Cue Biopharma, Inc. Quarterly Current Ratio in % from Q1 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cue Biopharma, Inc. quarterly Current Ratio history and growth rate from Q1 2019 to Q3 2024.
  • Cue Biopharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 244 %, a 45.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 244 -205 -45.6% Sep 30, 2024
Q2 2024 272 -245 -47.4% Jun 30, 2024
Q1 2024 312 -318 -50.4% Mar 31, 2024
Q4 2023 371 -313 -45.8% Dec 31, 2023
Q3 2023 449 -195 -30.2% Sep 30, 2023
Q2 2023 518 -74.9 -12.6% Jun 30, 2023
Q1 2023 630 +107 +20.4% Mar 31, 2023
Q4 2022 684 +203 +42.1% Dec 31, 2022
Q3 2022 644 +159 +32.8% Sep 30, 2022
Q2 2022 593 +62.9 +11.9% Jun 30, 2022
Q1 2022 524 -35.6 -6.37% Mar 31, 2022
Q4 2021 481 -76.3 -13.7% Dec 31, 2021
Q3 2021 485 -72.1 -13% Sep 30, 2021
Q2 2021 530 +53 +11.1% Jun 30, 2021
Q1 2021 559 +174 +45% Mar 31, 2021
Q4 2020 558 +203 +57% Dec 31, 2020
Q3 2020 557 +204 +58% Sep 30, 2020
Q2 2020 477 +38.4 +8.76% Jun 30, 2020
Q1 2020 386 -282 -42.2% Mar 31, 2020
Q4 2019 355 Dec 31, 2019
Q3 2019 352 Sep 30, 2019
Q2 2019 438 Jun 30, 2019
Q1 2019 667 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.